WO2002000001A3 - Recepteur igpcr20 couple a la proteine g humaine, et utilisations correspondantes - Google Patents

Recepteur igpcr20 couple a la proteine g humaine, et utilisations correspondantes Download PDF

Info

Publication number
WO2002000001A3
WO2002000001A3 PCT/EP2001/007533 EP0107533W WO0200001A3 WO 2002000001 A3 WO2002000001 A3 WO 2002000001A3 EP 0107533 W EP0107533 W EP 0107533W WO 0200001 A3 WO0200001 A3 WO 0200001A3
Authority
WO
WIPO (PCT)
Prior art keywords
igpcr20
protein
receptor
coupled receptor
express
Prior art date
Application number
PCT/EP2001/007533
Other languages
English (en)
Other versions
WO2002000001A2 (fr
Inventor
Frank Wattler
Sigrid Wattler
Paul Trommler
Michael C Nehls
Original Assignee
Ingenium Pharmaceuticals Ag
Frank Wattler
Sigrid Wattler
Paul Trommler
Michael C Nehls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingenium Pharmaceuticals Ag, Frank Wattler, Sigrid Wattler, Paul Trommler, Michael C Nehls filed Critical Ingenium Pharmaceuticals Ag
Priority to AU2001287574A priority Critical patent/AU2001287574A1/en
Publication of WO2002000001A2 publication Critical patent/WO2002000001A2/fr
Publication of WO2002000001A3 publication Critical patent/WO2002000001A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Cette invention se rapporte à une protéine du récepteur couplé à la protéine G humaine (GPcR), protéine appelée IGPcR20, qui a été identifiée et caractérisée. Des nucléotides codant IGPcR20, des protéines IGPcR20 et des protéines de fusion, des anticorps contre ce récepteur, des systèmes d'expression de cellules hôtes, des modèles animaux dans lesquels se produit une mutation du gène de la protéine IGPcR20, des animaux recombinés à gène inactivé qui n'expriment pas la protéine IGPcR20 et des animaux transgéniques qui expriment un transgène de IGPcR20 font également l'objet de cette invention, ainsi que des composés qui modulent l'expression génique ou l'activité récepteur de IGPcR20 et leur utilisation pour le criblage de médicaments et le diagnostic ou le traitement de maladies et d'affections, telles que notamment le cancer, les troubles de la reproduction et l'infertilité associés à un dysfonctionnement de l'épididyme.
PCT/EP2001/007533 2000-06-30 2001-07-02 Recepteur igpcr20 couple a la proteine g humaine, et utilisations correspondantes WO2002000001A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001287574A AU2001287574A1 (en) 2000-06-30 2001-07-02 Human g protein-coupled receptor igpcr20, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21577700P 2000-06-30 2000-06-30
US60/215,777 2000-06-30

Publications (2)

Publication Number Publication Date
WO2002000001A2 WO2002000001A2 (fr) 2002-01-03
WO2002000001A3 true WO2002000001A3 (fr) 2002-08-22

Family

ID=22804341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007533 WO2002000001A2 (fr) 2000-06-30 2001-07-02 Recepteur igpcr20 couple a la proteine g humaine, et utilisations correspondantes

Country Status (2)

Country Link
AU (1) AU2001287574A1 (fr)
WO (1) WO2002000001A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011731A (es) 2002-05-28 2005-02-14 Univ Minnesota Polipetidos cris como anticonceptivos e inhibidores de la capacitacion de espermatozoides.
WO2005059545A2 (fr) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g gpr82 (gpr82)
EP2125220A1 (fr) 2006-12-13 2009-12-02 Qiagen GmbH Microréseaux de transfection
WO2008124825A2 (fr) 2007-04-10 2008-10-16 Zimmer, Inc. Polyéthylène réticulé de très haut poids moléculaire stabilisé par des antioxydants pour des applications dans des dispositifs médicaux
LT2805720T (lt) 2008-05-28 2019-09-25 Reveragen Biopharma, Inc. Nehormoniniai steroidiniai nf-kb moduliatoriai, skirti ligoms gydyti
AU2009289496B2 (en) 2008-09-08 2014-04-10 Bally Gaming, Inc. Wagering game establishment data import/export architecture
EP3508239B1 (fr) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
AT508698B1 (de) * 2009-08-20 2017-07-15 Blum Gmbh Julius Möbel mit stellarmanordnung
US8819172B2 (en) 2010-11-04 2014-08-26 Digimarc Corporation Smartphone-based methods and systems
WO2011133825A1 (fr) * 2010-04-21 2011-10-27 Battelle Memorial Institute Fibres contenant des ferrates et procédés
US9200172B2 (en) * 2010-11-05 2015-12-01 City University Of Hong Kong Phthalocyanine/ polymer nanocomposite ink for optoelectonics
CN102469573B (zh) * 2010-11-16 2015-10-21 中兴通讯股份有限公司 一种物理下行控制信道符号数量的配置方法及装置
CN202069706U (zh) * 2011-02-28 2011-12-14 北京圣玛特科技有限公司 一种工作翼自带锁扣装置的金属自锁托槽
WO2012131670A2 (fr) 2011-03-28 2012-10-04 Rosetta Genomics Ltd Procédés pour la classification des cancers du poumon
US9848778B2 (en) 2011-04-29 2017-12-26 Medtronic, Inc. Method and device to monitor patients with kidney disease
US9253630B2 (en) 2011-06-02 2016-02-02 Truphone Limited Identity management for mobile devices
CN103155683B (zh) * 2011-06-27 2015-11-25 华为技术有限公司 实现lipa或sipto的移动性的方法和设备
BR122020024084B1 (pt) * 2011-07-21 2021-12-28 Basf Se Uso dos compostos
EP2758956B1 (fr) 2011-09-23 2021-03-10 Digimarc Corporation Logique des capteurs d'un smartphone basée sur le contexte
US8744766B2 (en) * 2011-09-27 2014-06-03 International Business Machines Corporation Dynamic route recommendation based on pollution data
WO2013094211A1 (fr) 2011-12-21 2013-06-27 パナソニック株式会社 Dispositif d'affichage
JP6106694B2 (ja) 2012-01-10 2017-04-05 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Ａｋｔキナーゼ阻害剤としての置換ピラゾロピリミジン類
EP3392347A1 (fr) 2012-04-02 2018-10-24 Life Technologies Corporation Compositions et procédés pour la détection de mycobacterium avium paratuberculosis
US9325569B2 (en) * 2012-06-29 2016-04-26 Hewlett Packard Enterprise Development Lp Implementing a software defined network using event records that are transmitted from a network switch
EP2913430B1 (fr) * 2012-10-29 2017-08-09 Panasonic Intellectual Property Management Co., Ltd. Dispositiv de réglage
US9311640B2 (en) 2014-02-11 2016-04-12 Digimarc Corporation Methods and arrangements for smartphone payments and transactions
JP5864637B2 (ja) 2013-03-19 2016-02-17 株式会社日立国際電気 半導体装置の製造方法、基板処理装置、プログラム及び記録媒体
US9369787B2 (en) * 2013-06-03 2016-06-14 Nokia Technologies Oy Shielded audio apparatus
US20150073515A1 (en) 2013-09-09 2015-03-12 Medtronic Ardian Luxembourg S.a.r.I. Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
DE102013017586A1 (de) 2013-10-17 2015-05-07 Turbolite Vertriebs Gmbh BEHANDLUNGSGERÄT für magnetfeldunterstützte BESTRAHLUNGSTHERAPIEN
DE102013018179A1 (de) 2013-11-29 2015-06-03 Michael Feldmann Verfahren und Einrichtungen zur Erzeugung absolut treibhausgasfreier Kraftstoffe
US9869658B2 (en) 2014-07-22 2018-01-16 International Business Machines Corporation Electronic label free detection of DNA complexes using nanogap
AU2014414847B2 (en) 2014-12-22 2018-02-01 Colgate-Palmolive Company Unit dose fabric softener
DE202015000313U1 (de) 2015-01-13 2015-03-20 Eugen Sarpaczki Gasmischeinrichtung
FR3032686B1 (fr) 2015-02-18 2017-03-10 Messier Bugatti Dowty Atterrisseur d'aeronef comprenant une tige lineaire telescopique
WO2016167787A1 (fr) * 2015-04-17 2016-10-20 Halliburton Energy Services, Inc. Agents améliorant l'indice de viscosité et agents de régulation de filtration à utiliser dans des opérations souterraines à température élevée
EP3106256A1 (fr) 2015-06-19 2016-12-21 Meyer Burger AG Procédé pour découper une pièce
DE102016002678A1 (de) 2016-03-08 2017-09-14 GASKATEL Gesellschaft für Gassysteme durch Katalyse und Elektrochemie mbH Voltammetrische Messzelle
US11197637B2 (en) 2016-06-20 2021-12-14 Faurecia Automotive Seating, Llc Control system for a vehicle seat
EP3301898A1 (fr) 2016-09-29 2018-04-04 British Telecommunications public limited company Procédé et appareil pour transmettre des données depuis un dispositif émetteur à un ou plusieurs dispositifs de réception
DE202016006615U1 (de) 2016-10-26 2018-01-30 WIK - ELEKTROGERÄTE Entwicklungs- und Service-GmbH & Co. KG Haarformgerät zur Beaufschlagung eines Pflegestoffes mittels Druckluft
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2001048189A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a une proteine de liaison au guanosine triphosphate, genes de ces derniers, et production et utilisation de ces derniers
WO2001059109A1 (fr) * 2000-02-08 2001-08-16 Millennium Pharmaceuticals, Inc. Proteine a sept segments transmembranaires appelee proteine 39406
WO2001062797A2 (fr) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company Nouveaux recepteurs couples a la proteine g

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2001048189A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a une proteine de liaison au guanosine triphosphate, genes de ces derniers, et production et utilisation de ces derniers
WO2001059109A1 (fr) * 2000-02-08 2001-08-16 Millennium Pharmaceuticals, Inc. Proteine a sept segments transmembranaires appelee proteine 39406
WO2001062797A2 (fr) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company Nouveaux recepteurs couples a la proteine g

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBL; 16 March 2000 (2000-03-16), "Human DNA sequence", XP002200943, Database accession no. AL161458 *
SCHONEBERG T ET AL: "A novel subgroup of class I G-protein-coupled receptors", BIOCHIMICA ET BIOPHYSICA ACTA. GENE STRUCTURE AND EXPRESSION, ELSEVIER, AMSTERDAM, NL, vol. 1446, no. 1-2, 7 July 1999 (1999-07-07), pages 57 - 70, XP004275425, ISSN: 0167-4781 *
STADEL J M ET AL: "Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 18, no. 11, 1 November 1997 (1997-11-01), pages 430 - 437, XP004099345, ISSN: 0165-6147 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease

Also Published As

Publication number Publication date
AU2001287574A1 (en) 2002-01-08
WO2002000001A2 (fr) 2002-01-03

Similar Documents

Publication Publication Date Title
WO2002000001A3 (fr) Recepteur igpcr20 couple a la proteine g humaine, et utilisations correspondantes
Zhang et al. Mechanically activated piezo channels mediate touch and suppress acute mechanical pain response in mice
Mintz et al. EHD1—an EH-domain-containing protein with a specific expression pattern
ATE430198T1 (de) Antikörperkonstruktion unter verwendung einer mrl/lpr-maus
NZ516004A (en) Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
Munoz et al. Expression and function of the Eph A receptors and their ligands ephrins A in the rat thymus
CN111019953A (zh) 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物
JP2001523977A (ja) Ａｐａｆ−１、ｃｅｄ−４ヒト相同体、カスパーゼ−３の活性化因子
DK0647275T3 (da) Kloning og ekspression af receptoren for gonatotropin-frigörende hormon
WO2002002599A3 (fr) Recepteur couple aux proteines g humaines igpcr17, et son utilisation
WO2002002598A3 (fr) Recepteur couple a la proteine g humaine igpcr18 et utilisations correspondantes
WO2002002600A3 (fr) Recepteur couple a une proteine g chez l'homme, igpcr27 et utilisations de ce dernier
WO2002000689A3 (fr) Igpcr11, recepteur humain couple a la proteine g et utilisations correspondantes
Pilpel et al. Molecular biology of olfactory receptors
Herman Touch sensation in Caenorhabditis elegans
CN1898263B (zh) 编码新的前列腺素受体蛋白的核酸及其使用方法
Li et al. Heterologous expression of the adenosine A1 receptor in transgenic mouse retina
Beekman et al. Protein 4.1 G binds to a unique motif within the FcγRI cytoplasmic tail
MX2021008291A (es) Un modelo de roedor de trastornos del estado de animo.
US20020115069A1 (en) Eh domain containing genes and proteins
Li et al. Belly roll, a GPI-anchored Ly6 protein, regulates Drosophila melanogaster escape behaviors by modulating the excitability of nociceptive peptidergic interneurons
ATE540965T1 (de) Ob-rezeptor und verfahren zur diagnose und behandlung von gewicht
JP3842647B2 (ja) インターロイキン−１レセプターアンタゴニスト関連分子およびその使用
JP4934397B2 (ja) トランスジェニック非ヒト動物
Munro Mutational analysis of Drosophila Basigin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP